CWRU‘s pain neurostimulation spinout has secured series BB funding ahead of a 180-patient trial.

Neuros Medical, a US-based pain treatment spinout of Case Western Reserve University, raised $38.5m yesterday in a series BB round backed by spinout-focused investment firm Osage University Partners.
Investment advisory firm Sectoral Asset Management and Amzak Health, a vehicle for asset management Amzak Capital Management, co-led the round with further from participation  InCube Ventures, US Venture Partners, Aperture Venture Partners and undisclosed investors.
A regulatory filing suggests most of the money was secured in November 2020.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?